{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:47:23Z","timestamp":1791488843563,"version":"4.3.4"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T00:00:00Z","timestamp":1603324800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Incepta pharmaceuticals limited, Bangladesh"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EClinicalMedicine"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.eclinm.2020.100624","type":"journal-article","created":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T23:28:01Z","timestamp":1605914881000},"page":"100624","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Investigation of the efficacy and safety of eltrombopag to correct thrombocytopenia in moderate to severe dengue patients - a phase II randomized controlled clinical trial"],"prefix":"10.1016","volume":"29-30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8900-503X","authenticated-orcid":false,"given":"Sajib","family":"Chakraborty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saruar","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Sayem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mousumi","family":"Sanyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonmoy","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piyal","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Sayem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartholomia Keya","family":"Byapari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chowdhury Tamanna","family":"Tabassum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmedul","family":"Kabir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md.Robed","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0504-6556","authenticated-orcid":false,"given":"A.H.M. Nurun","family":"Nabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10169","key":"10.1016\/j.eclinm.2020.100624_bib0001","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0140-6736(18)32560-1","article-title":"Dengue","volume":"393","author":"Wilder-Smith","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2020.100624_bib0002","doi-asserted-by":"crossref","first-page":"16055","DOI":"10.1038\/nrdp.2016.55","article-title":"Dengue infection","volume":"2","author":"Guzman","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"suppl_2","key":"10.1016\/j.eclinm.2020.100624_bib0003","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1093\/infdis\/jiw649","article-title":"Clinical and Laboratory diagnosis of dengue virus infection","volume":"215","author":"Muller","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.eclinm.2020.100624_bib0004","unstructured":"World Health Organization ROfS-EAW, SEARO). Comprehensive guidelines for prevention and control of dengue and dengue haemorrhagic fever. 2011."},{"issue":"12 Suppl","key":"10.1016\/j.eclinm.2020.100624_bib0005","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1038\/nrmicro2460","article-title":"Dengue: a continuing global threat","volume":"8","author":"Guzman","year":"2010","journal-title":"Nat Rev Microbiol"},{"issue":"4 Suppl","key":"10.1016\/j.eclinm.2020.100624_bib0006","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2149\/tmh.2011-S10","article-title":"Clinical manifestations and management of dengue\/DHF\/DSS","volume":"39","author":"Kalayanarooj","year":"2011","journal-title":"Trop Med Health"},{"issue":"4","key":"10.1016\/j.eclinm.2020.100624_bib0007","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005498","article-title":"The value of daily platelet counts for predicting dengue shock syndrome: results from a prospective observational study of 2301 Vietnamese children with dengue","volume":"11","author":"Lam","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"10.1016\/j.eclinm.2020.100624_bib0008","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1186\/s13104-018-3505-4","article-title":"Value of peripheral blood count for dengue severity prediction","volume":"11","author":"Ralapanawa","year":"2018","journal-title":"BMC Res Notes"},{"issue":"1","key":"10.1016\/j.eclinm.2020.100624_bib0009","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4103\/0973-6247.28065","article-title":"Role of platelet transfusion in the management of dengue patients in a tertiary care hospital","volume":"1","author":"Makroo","year":"2007","journal-title":"Asian J Transfus Sci"},{"issue":"11","key":"10.1016\/j.eclinm.2020.100624_bib0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007837","article-title":"Dengue viruses infect human megakaryocytes, with probable clinical consequences","volume":"13","author":"Vogt","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.eclinm.2020.100624_bib0011","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/313842","article-title":"Thrombocytopenia in dengue: interrelationship between virus and the imbalance between coagulation and fibrinolysis and inflammatory mediators","volume":"2015","author":"de Azeredo","year":"2015","journal-title":"Mediat Inflamm."},{"issue":"5","key":"10.1016\/j.eclinm.2020.100624_bib0012","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/jth.12178","article-title":"Dengue induces platelet activation, mitochondrial dysfunction and cell death through mechanisms that involve DC-SIGN and caspases","volume":"11","author":"Hottz","year":"2013","journal-title":"J Thromb Haemost: JTH"},{"issue":"10079","key":"10.1016\/j.eclinm.2020.100624_bib0013","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/S0140-6736(17)30269-6","article-title":"Prophylactic platelet transfusion plus supportive care versus supportive care alone in adults with dengue and thrombocytopenia: a multicentre, open-label, randomised, superiority trial","volume":"389","author":"Lye","year":"2017","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1016\/j.eclinm.2020.100624_bib0014","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.4103\/2229-516X.140708","article-title":"Transfusion support in patients with dengue fever","volume":"4","author":"Kaur","year":"2014","journal-title":"Int J Appl Basic Med Res"},{"issue":"5","key":"10.1016\/j.eclinm.2020.100624_bib0015","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1182\/blood.V98.5.1339","article-title":"Thrombopoietin therapy increases platelet yields in healthy platelet donors","volume":"98","author":"Kuter","year":"2001","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.eclinm.2020.100624_bib0016","doi-asserted-by":"crossref","first-page":"673","DOI":"10.7326\/0003-4819-126-9-199705010-00001","article-title":"Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patients with cancer","volume":"126","author":"Vadhan-Raj","year":"1997","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.eclinm.2020.100624_bib0017","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1182\/blood.V98.12.3241","article-title":"Thrombocytopenia caused by the development of antibodies to thrombopoietin","volume":"98","author":"Li","year":"2001","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.eclinm.2020.100624_bib0018","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1159\/000355006","article-title":"Clinical indications for thrombopoietin and thrombopoietin-receptor agonists","volume":"40","author":"Wormann","year":"2013","journal-title":"Transfus Med Hemother: Off Organ Deutsch Ges Transfus Med Immunhamatol"},{"issue":"5","key":"10.1016\/j.eclinm.2020.100624_bib0019","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jval.2016.03.1856","article-title":"Cost-effectiveness of eltrombopag versus romiplostim for the treatment of chronic immune thrombocytopenia in England and Wales","volume":"19","author":"Allen","year":"2016","journal-title":"Value Health: J Int Soc Pharmacoecon Outcomes Res"},{"issue":"22","key":"10.1016\/j.eclinm.2020.100624_bib0020","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1056\/NEJMoa073275","article-title":"Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura","volume":"357","author":"Bussel","year":"2007","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.eclinm.2020.100624_bib0021","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1056\/NEJMoa1110709","article-title":"Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia","volume":"367","author":"Afdhal","year":"2012","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.eclinm.2020.100624_bib0022","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJMoa1613878","article-title":"Eltrombopag added to standard immunosuppression for aplastic anemia","volume":"376","author":"Townsley","year":"2017","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.eclinm.2020.100624_bib0023","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/2040620717693573","article-title":"From chronic immune thrombocytopenia to severe aplastic anemia: recent insights into the evolution of eltrombopag","volume":"8","author":"Gill","year":"2017","journal-title":"Ther Adv Hematol"},{"issue":"2","key":"10.1016\/j.eclinm.2020.100624_bib0024","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1634\/stemcells.2008-0366","article-title":"Preclinical activity of eltrombopag (SB-497115), an oral, nonpeptide thrombopoietin receptor agonist","volume":"27","author":"Erickson-Miller","year":"2009","journal-title":"Stem Cells"},{"issue":"1","key":"10.1016\/j.eclinm.2020.100624_bib0025","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S1658-3876(11)50062-7","article-title":"Romiplostim reverts the thrombocytopenia in dengue hemorrhagic fever","volume":"4","author":"Rodriguez-Mejorada","year":"2011","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"4 Pt 2","key":"10.1016\/j.eclinm.2020.100624_bib0026","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1016\/j.lpm.2014.02.008","article-title":"Thrombopoietic agents: there is still much to learn","volume":"43","author":"Bussel","year":"2014","journal-title":"Presse medicale"},{"issue":"6","key":"10.1016\/j.eclinm.2020.100624_bib0027","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.3324\/haematol.2018.212845","article-title":"Thrombopoietin receptor agonists: ten years later","volume":"104","author":"Ghanima","year":"2019","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.eclinm.2020.100624_bib0028","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/cid\/cir451","article-title":"Dengue-how best to classify it","volume":"53","author":"Srikiatkhachorn","year":"2011","journal-title":"Clin Infecti Dis: Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.eclinm.2020.100624_bib0029","article-title":"Comprehensive guideline for prevention and control of dengue and dengue haemorrhagic fever. revised and expanded edition","year":"2011","journal-title":"WHO Reg Office South-East Asia"},{"issue":"6","key":"10.1016\/j.eclinm.2020.100624_bib0030","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrcardio.2014.40","article-title":"Cardiovascular manifestations of the emerging dengue pandemic","volume":"11","author":"Yacoub","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.eclinm.2020.100624_bib0031","article-title":"Manual on the management, maintenance and use of blood cold chain equipment","year":"2005","journal-title":"WHO Reg Office South-East Asia"},{"issue":"6","key":"10.1016\/j.eclinm.2020.100624_bib0032","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1111\/j.1537-2995.2012.03918.x","article-title":"Measurement of the absolute immature platelet number reflects marrow production and is not impacted by platelet transfusion","volume":"53","author":"Bat","year":"2013","journal-title":"Transfusion"},{"issue":"8","key":"10.1016\/j.eclinm.2020.100624_bib0033","doi-asserted-by":"crossref","first-page":"e315","DOI":"10.1016\/S2352-3026(15)00114-3","article-title":"Eltrombopag for the treatment of children with persistent and chronic immune thrombocytopenia (PETIT): a randomised, multicentre, placebo-controlled study","volume":"2","author":"Bussel","year":"2015","journal-title":"Lancet Haematol"},{"issue":"3","key":"10.1016\/j.eclinm.2020.100624_bib0034","first-page":"227","article-title":"Explaining odds ratios","volume":"19","author":"Szumilas","year":"2010","journal-title":"J Can Acad Child Adolesc Psychiatry"},{"issue":"16","key":"10.1016\/j.eclinm.2020.100624_bib0035","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1056\/NEJMoa054626","article-title":"AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP","volume":"355","author":"Bussel","year":"2006","journal-title":"N Engl J Med"},{"issue":"9664","key":"10.1016\/j.eclinm.2020.100624_bib0036","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0140-6736(09)60402-5","article-title":"Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial","volume":"373","author":"Bussel","year":"2009","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.eclinm.2020.100624_bib0037","doi-asserted-by":"crossref","first-page":"4739","DOI":"10.1182\/blood-2006-11-057968","article-title":"Phase 1 clinical study of eltrombopag, an oral, nonpeptide thrombopoietin receptor agonist","volume":"109","author":"Jenkins","year":"2007","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.eclinm.2020.100624_bib0038","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1083\/jcb.201304054","article-title":"The incredible journey: from megakaryocyte development to platelet formation","volume":"201","author":"Machlus","year":"2013","journal-title":"J Cell Biol"},{"issue":"3","key":"10.1016\/j.eclinm.2020.100624_bib0039","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1083\/jcb.201410052","article-title":"IL-1alpha induces thrombopoiesis through megakaryocyte rupture in response to acute platelet needs","volume":"209","author":"Nishimura","year":"2015","journal-title":"J Cell Biol"},{"issue":"1","key":"10.1016\/j.eclinm.2020.100624_bib0040","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41467-017-00201-7","article-title":"Thrombopoiesis is spatially regulated by the bone marrow vasculature","volume":"8","author":"Stegner","year":"2017","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.eclinm.2020.100624_bib0041","doi-asserted-by":"crossref","DOI":"10.3390\/jcm6020016","article-title":"Pathogenesis and therapeutic mechanisms in immune thrombocytopenia (ITP)","volume":"6","author":"Zufferey","year":"2017","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.eclinm.2020.100624_bib0042","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1182\/blood-2003-08-2672","article-title":"Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP","volume":"103","author":"McMillan","year":"2004","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.eclinm.2020.100624_bib0043","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1007\/s12185-012-1175-x","article-title":"Role of CD61+ cells in thrombocytopenia of dengue patients","volume":"96","author":"Noisakran","year":"2012","journal-title":"Int J Hematol"},{"key":"10.1016\/j.eclinm.2020.100624_bib0044","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.thromres.2016.06.002","article-title":"Immature platelet fraction predicts coagulopathy-related platelet consumption and mortality in patients with sepsis","volume":"144","author":"Muronoi","year":"2016","journal-title":"Thromb Res"},{"key":"10.1016\/j.eclinm.2020.100624_bib0045","doi-asserted-by":"crossref","first-page":"41697","DOI":"10.1038\/srep41697","article-title":"Platelet activation determines the severity of thrombocytopenia in dengue infection","volume":"7","author":"Ojha","year":"2017","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.eclinm.2020.100624_bib0046","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1038\/ng.467","article-title":"A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium","volume":"41","author":"Soranzo","year":"2009","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.eclinm.2020.100624_bib0047","doi-asserted-by":"crossref","first-page":"125","DOI":"10.12998\/wjcc.v3.i2.125","article-title":"Dengue and its effects on liver","volume":"3","author":"Samanta","year":"2015","journal-title":"World J Clin Cases"}],"container-title":["EClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537020303680?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537020303680?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T19:04:03Z","timestamp":1762887843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537020303680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":47,"alternative-id":["S2589537020303680"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2020.100624","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigation of the efficacy and safety of eltrombopag to correct thrombocytopenia in moderate to severe dengue patients - a phase II randomized controlled clinical trial","name":"articletitle","label":"Article Title"},{"value":"EClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2020.100624","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100624"}}